1

Welcome

2

Apologies

3

Confirmation of the minutes of the 106th meeting held on 27 March 2018

4

Declaration of conflicts of interest

5

Matters arising

5.1

Out-of-session meeting for Liposomal Doxorubicin SUN
2 mg/mL concentrate for infusion (TT50-9159)
Pharmacy Retailing (NZ) Ltd

The Committee made a recommendation about this application. The recommendation was not published because the applicant withdrew this application on 16 October 2018, following notification of the recommendation.

6

Applications for consent to distribute a new medicine under section 20 / 23 / 24 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))

7

Review of evaluation reports

7.1

Enlafax XR (venlafaxine) 37.5 mg, 75 mg and 150 mg modified release capsule (TT50-7992, a, b)

8

General business

9

Date of next meeting